Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2017 19:30 ET | Source: Cutting Edge Information

New Research Finds Phase 3 is the Most Popular Stage for Medical Affairs Teams to Begin Thought Leader Development Activities

RESEARCH TRIANGLE PARK, NC--(Marketwired - May 08, 2017) - Between both Phase 3a and 3b, 50% of surveyed teams begin their thought leader development activities, with the next most popular stage to...
February 21, 2017 08:36 ET | Source: Cutting Edge Information

FMV Budget is a Top Criterion Among Surveyed Companies When Evaluating IIT Proposals

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 21, 2017) - Nearly one-third of surveyed pharmaceutical companies look to fair-market value (FMV) budget as one their most important criteria for...
January 26, 2017 07:39 ET | Source: Cutting Edge Information

Medical Affairs Teams Undertake Launch Planning Activities as Early as Three Years Ahead of Product Launch, Says New Research

RESEARCH TRIANGLE PARK, NC--(Marketwired - January 26, 2017) - Launch planning is an essential component of life science teams' ongoing activities. As new life science products approach the launch...
October 11, 2016 09:08 ET | Source: Cutting Edge Information

Pharma to Clinical Investigators: Reach Target Patient Enrollment or You Don't Get Paid

RESEARCH TRIANGLE PARK, NC--(Marketwired - October 11, 2016) - A study published by Cutting Edge Information found that 87% of surveyed pharmaceutical companies would not submit next-level clinical...
June 28, 2016 08:17 ET | Source: Cutting Edge Information

77% of Investigator-Initiated Trial Committees With Complete Voting Privileges Let High-Level Executives Make Final Decisions

RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - Investigator-initiated trial (IIT) review committees are often small and contain individuals from a variety of backgrounds. Most...
March 03, 2010 09:17 ET | Source: Cutting Edge Information

75 Percent of Drug Companies Formally Manage Investigator-Initiated Trials

RESEARCH TRIANGLE PARK, NC--(Marketwire - March 3, 2010) - Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a...